| Literature DB >> 32833196 |
Giuseppe Rovere1, Agostino Meduri1, Giancarlo Savino1, Francesco Ciriaco Flammia1, Francesca Lo Piccolo1, Maria Rachele Pia Carafa1, Anna Rita Larici1, Luigi Natale1, Biagio Merlino1, Riccardo Marano2.
Abstract
The progressive increase in numbers of noninvasive cardiac imaging examinations broadens the spectrum of knowledge radiologists are expected to acquire in the management of drugs during CT coronary angiography (CTCA) and cardiac MR (CMR) to improve image quality for optimal visualization and assessment of the coronary arteries and adequate MR functional analysis. Aim of this review is to provide an overview on different class of drugs (nitrate, beta-blockers, ivabradine, anxiolytic, adenosine, dobutamine, atropine, dipyridamole and regadenoson) that can be used in CTCA and CMR, illustrating their main indications, contraindications, efficacy, mechanism of action, metabolism, safety, side effects or complications, and providing advices in their use.Entities:
Keywords: Adenosine; Adrenergic beta-Antagonists; Anti-Anxiety Agents; Atropine; Computed Tomography Angiography; Contraindications; Coronary Vessels; Dipyridamole; Dobutamine; Ivabradine; Magnetic Resonance Imaging; Regadenoson
Year: 2020 PMID: 32833196 DOI: 10.1007/s11547-020-01261-4
Source DB: PubMed Journal: Radiol Med ISSN: 0033-8362 Impact factor: 3.469